Rehabilitation Before and After Autologous Haematopoietic Stem Cell Transplantation (AHSCT) for Patients With Multiple Sclerosis (MS): Consensus Guidelines and Recommendations for Best Clinical Practice on Behalf of the Autoimmune Diseases Working Party, Nurses Group, and Patient Advocacy Committee of the European Society for Blood and Marrow Transplantation (EBMT)

Autologous haematopoietic stem cell transplantation (AHSCT) is increasingly used to treat people with multiple sclerosis (MS). Supported by an evolving evidence base, AHSCT can suppress active inflammation in the central nervous system and induce long-term changes in immune cell populations, thereby...

Descripción completa

Detalles Bibliográficos
Autores principales: Roberts, Fiona, Hobbs, Helen, Jessop, Helen, Bozzolini, Cristina, Burman, Joachim, Greco, Raffaella, Ismail, Azza, Kazmi, Majid, Kirgizov, Kirill, Mancardi, Gianluigi, Mawson, Susan, Muraro, Paolo A., Puyade, Mathieu, Saccardi, Riccardo, Withers, Barbara, Verhoeven, Bregje, Sharrack, Basil, Snowden, John A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759663/
https://www.ncbi.nlm.nih.gov/pubmed/33362684
http://dx.doi.org/10.3389/fneur.2020.556141

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759663/
https://www.ncbi.nlm.nih.gov/pubmed/33362684
http://dx.doi.org/10.3389/fneur.2020.556141

Ejemplares similares